EBITDA Growth Masks a Net Loss; ₹57 Crore Credibility Gap Questions Management

On the earnings call, the MD painted a confident picture: "PAT was about INR 53.2 crores, which is against INR 8.4 crores last year, roughly a 6.5x jump." But the statutory filing tells a starkly different story. WeWork India delivered a net loss of ₹4.1 crores for Q1 FY-2027—not a profit at all. That's a ₹57.3 crore gap between what management claimed and what was filed. No reconciliation was offered on the call, and the market noticed. The stock fell 6.88% on day 1 post-result; the decline held—it didn't reverse by day 3 (still −1.16%).

The claim rests on EBITDA: reported at ₹138 crores (19.8% margin, up 69% YoY), and that number is solid. Revenue growth (28.5% YoY to ₹683.8 Cr) is real. Member count (113,000, up 30% YoY) is climbing fast. Occupancy (84.9%, up 8 percentage points) validates pricing power. But the problem sits downstream: capex and depreciation.

WeWork invested ₹188 crores in capex in Q1 alone—nearly double the ₹94 crores spent a year ago. The company is guiding ₹500–600 crores for the full FY27, adding 22,000 desks in H1. Growth centers sit at 65% occupancy; mature centers hold steady at 87.5%. The narrative is clear: fill the new centers in H2, occupancy ramps, EBITDA per desk expands, profitability recovers. But that timeline carries two critical risks: (1) occupancy must ramp faster than capacity additions, and (2) macro must hold. Neither is guaranteed.

The sequential revenue picture is telling. Q1 revenue of ₹683.8 Cr is down 1.8% from Q4 FY-2026 (₹695 Cr). Management never mentioned this decline on the call—they led on YoY (+28.5%) and sidestepped the QoQ weakness. That sequential drag, combined with doubled capex and a loss-making quarter, suggests the capex cycle is already biting into profitability harder than management wants to admit.

On the Q4 FY-2026 call, management promised "over 20% year-over-year top-line growth, driven by a deep order book and significant capacity expansion." Q1 delivered 28.5% revenue growth and 69% EBITDA growth—beating that bar. But profitability flipped: from implied profit to a net loss. Capex doubled to ₹188 crores. Customization revenue accounting shifted to amortize lumpy deals over contract terms (hiding deal economics). The tone shifted from "profitable expansion" to "growth cycle"—a polite term for depressed near-term profit. Management deflected PAT questions by pivoting to EBITDA and cash flow (operating FCF up 176% to ₹141.9 Cr), neither of which is the statutory bottom line.

The market's verdict is clear: the loss quarter was not priced in. On day 1 post-result, the stock fell 6.88%; by day 3, it was still down 1.16% cumulatively. The shock held—it didn't fade. Current price of ₹715.15 is 6.76% below the all-time high of ₹767, yet still up 70.27% from the 52-week low of ₹420—suggesting the stock had run too far on optimism before earnings.

On ownership, FII trimmed to 20.37% (down 161 basis points from Q3 FY-2026), a quiet but important vote of no confidence. Institutions bought on the growth story; they're selling on the profitability miss. DII rose slightly to 25.61% (up 77 bps), and promoters hold 49.42% (down 38 bps). Promoter ownership is stable but constrained by a ₹570 Cr debt pledge against shares—if the stock falls another 15–20%, pledging risk becomes real.

Valuation sits neutral: stock is well above SMA20 (₹707) and SMA50 (₹636), but RSI at 43.2 signals neither overbought nor oversold. Volume is increasing. Without clarity on PAT recovery, the stock likely stays rangebound (₹680–₹740) until Q2 results clarify occupancy acceleration and profitability path.